| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |